Advertisement
Update in office management| Volume 122, ISSUE 2, P121-125, February 2009

Atopic Dermatitis

  • Nancy Wasserbauer
    Affiliations
    Department of Pediatrics, Division of Allergy and Immunology, Women's & Children Hospital of Buffalo, State University of New York at Buffalo, School of Medicine and Biomedical Sciences
    Search for articles by this author
  • Mark Ballow
    Correspondence
    Requests for reprints should be addressed to Mark Ballow, MD, Department of Pediatrics, Division of Allergy and Clinical Immunology, Women and Children's Hospital of Buffalo, 219 Bryant St., Buffalo, NY 14222
    Affiliations
    Department of Pediatrics, Division of Allergy and Immunology, Women's & Children Hospital of Buffalo, State University of New York at Buffalo, School of Medicine and Biomedical Sciences
    Search for articles by this author
      Atopic dermatitis (AD), also called eczema, is a chronic inflammatory skin condition that is genetically transmitted and affects 10-20% of the pediatric population and 1-3% of the adult population.
      • Leung D.Y.M.
      • Nicklas R.A.
      • Li J.T.
      • et al.
      Disease management of atopic dermatitis: an updated practice parameter.
      Less than 20% of adults with AD have the onset of disease after adolescence.
      • Akdis C.A.
      • Akdis M.
      • Bieber T.
      • et al.
      Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report.
      It is important for the primary care physician to understand how to diagnose and manage this condition as well as when to refer the patient for specialty consultation.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Leung D.Y.M.
        • Nicklas R.A.
        • Li J.T.
        • et al.
        Disease management of atopic dermatitis: an updated practice parameter.
        Ann Allergy Asthma Immunol. 2004; 93: S1-S21
        • Akdis C.A.
        • Akdis M.
        • Bieber T.
        • et al.
        Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report.
        J Allergy Clin Immunol. 2006; 118: 152-169
        • Koblenzer C.
        Itching and the atopic skin.
        J Allergy Clin Immunol. 1999; 104: S109-S113
        • Beltrani V.S.
        The clinical spectrum of atopic dermatitis.
        J Allergy Clin Immunol. 1999; 104: S87-S98
        • Sicherer S.
        • Sampson H.
        Food hypersensitivity and atopic dermatitis; pathophysiology, epidemiology and management.
        J Allergy Clin Immunol. 1999; 104: S114-S122
        • Joly P.
        • Benoit-Corven C.
        • Baricault S.
        • et al.
        Chronic eczematous eriptions o fthe elderly are associated with chronic exposure to calcium channel blockers:results from a case-control study.
        J Invest Dermatol. 2007; 127: 2766-2771
        • Hanifin J.
        • Rajka G.
        Diagnostic features of atopic dermatitis.
        Acta Derm Venereol. 1980; 92: 44-47
        • Hanifin J.
        • Cooper K.
        • Ho V.
        • et al.
        Guidelines of care for atopic dermatitis: Outcomes Task Force.
        J Amer Acad Dermatol. 2004; 50: 391-404
        • Berth-Jones J.
        • Damstra R.
        • Golsch S.
        • et al.
        Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double-blind, parallel group study.
        Br Med J. 2003; 326: 1367-1373
        • Ashcroft D.M.
        • Dimmock P.
        • Garside R.
        • et al.
        Efficacy and tolerability of topical pimecrolimus and tacrolims in the treatment of atopic dermatitis: meta-analysis of randomized controlled trials.
        Br Med J. 2005; 333: 516-525
        • Nghiem P.
        • Pearson G.
        • Langley R.
        Tacrolimus and pimecrolimus: From clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis.
        J Amer Acad Dermatol. 2002; 46: 228-241